OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Cardiology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Error in Table 1	444
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	272
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	267
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	259
Primary Prevention Management of Elevated Lipoprotein(a)	233
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	222
A Woman With Recurrent Torsade de Pointes	185
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	182
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	173
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	164
Chest Pain in a Middle-Aged Man	163
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	157
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	154
JAMA Cardiology	150
Accountable Care Organization Participation and Cardiovascular Care Quality	148
JAMA Cardiology	140
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals	138
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	128
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	127
USPSTF Report on Aspirin for Primary Prevention	121
Midlife Wealth Mobility and Long-term Cardiovascular Health	121
Genome-Wide Association Study of Accessory Atrioventricular Pathways	119
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	109
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	102
Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	102

Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	101
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	101
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	97
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	96
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	95
JAMA Cardiology	94
What Is Your Secret to Health?	92
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	91
Supraventricular Tachycardia Following Mitral Valve Surgery	89
Assessing Performance of Machine Learning—Reply	86
JAMA Cardiology	85
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	84
Hypertriglyceridemia in the MESA Study—Reply	83
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	82
User Trust in Artificial Intelligence–Guided Lung Ultrasound	81
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	79
Contribution of Clinical Trial Event Data by Data Source	79
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	78
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	78
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	78
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	78
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	77
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	75
Innovation in Event Adjudication—Human vs Machine	75
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	74
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	74
Peak Oxygen Uptake vs Ventilatory Efficiency	72
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	71
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	70
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	69
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	69
Change to Open Access Status	65
Corrected to Open Access Status	65
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	64
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	64
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	64
JAMA Cardiology	63
Error in Figure	62
Young Man With Coarctation of the Aorta	62
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	61
JAMA Cardiology	61
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	60
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	58
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US	57
An Expanded Heart Failure Indication for Sacubitril/Valsartan	57
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	56
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	56
Exercise Capacity in Young Adults Born Small for Gestational Age	56
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	55
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	55

Optimizing Cascade Testing to Advance Health Equity in Cardiac Amyloidosis	55
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	54
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	53
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	52
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	52
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation	52
PCSK9 in Familial Hypercholesterolemia and Beyond	51
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events	51
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors	51
Passing the Stethoscope	50
A Woman With Syncope and Frequent Premature Ventricular Contractions	49
To Occlude or Not to Occlude the Left Atrial Appendage in Women	49
JAMA Cardiology	49
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	49
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	47
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	47
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	47
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	46
Error in Abstract and Results	46
Error in Figure 1	46
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	46
Troponins and Pregnancy—Reply	46
Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications	45
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	45
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	44
Preserving and Promoting Clinical Trial Representativeness	44
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	44
The 3.5-Inch View—On Perspective and the Medical Profession	43
When Is a Placebo Not a Placebo	43
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	43
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	43
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	42
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	42
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	42
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	42
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	42
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	42
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	41
Clonal Hematopoiesis—Fuel to Inflame the Heart	41
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	41
Early Mortality in Type A Acute Aortic Dissection	41
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	40
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	39
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	39
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	38
A Patient in Their 30s With Dyspnea and a Spongy Heart	38
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	37
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	37
An Elderly Woman With Ventricular Tachycardia	36
JAMA Cardiology	36
Incidental Complication From a Left Atrial Appendage Device	36
In Honor of the Pig	36
Expanding Discovery in Cardiovascular Genome-Wide Association Studies	36
JAMA Cardiology	35
JAMA Cardiology	35
My Grandfather’s Blueprint	35
Reflections of an Editorial Fellow—A Window Into Medical Publishing	34
Errors in Key Points, Abstract, Results, and Figures	34
Error in Results	33
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	33
Errors in Author Affiliations and Open Access Updated	33
The Limitations and Risks Associated With Semaglutide Treatment—Reply	33
One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation	33
Error in Table	33
Error in Abstract	33
The Last Mile in Prevention—Can Coronary CT Angiography Help?	33
Corrected to Open Access Status	33
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	33
PREVENT Risk Age Equations and Population Distribution in US Adults	32
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	32
Myocardial Infarction and Evolocumab	32
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	32
Preventing Declines in Cardiovascular Health From Childhood	32
Finerenone in Heart Failure—Reply	32
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension—Reply	32
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	32
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	31
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	31
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk	31
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	31

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	31
JAMA Cardiology	30
Bizarre Wide-Complex Tachycardia in a Man in His 60s With Severe Chest Pain	30
Medicine, Writing, and the Limits of Language	30
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	30
A Man in His 60s With Severe Heart Failure and Incessant Ventricular Arrhythmias	30
Error in Corresponding Author Information	30
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	29
A Young Woman With Dyspnea During Cardiac Catheterization	29
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	29
Moving Beyond Conventional Guesstimation to Guide PCI	29
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	29
Updated USPSTF Guidelines for Screening for Atrial Fibrillation	29
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	28
Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	28
Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018	28
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes	27
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	27
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	27
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	27
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	27
Comment on Aspirin Avoidance in Patients With LVADs	27
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	27
JAMA Cardiology	27
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	26
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	26
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	26
Troubleshooting CardioMEMS After Implant—Failure to Read	26
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	25
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	25
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	25
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	25
JAMA Cardiology	25
A Teenager With Palpitations	25
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	24
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	24
Patient Enrollment for Cardiovascular Clinical Trials in the United States	24
JAMA Cardiology	24
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	23
The Fine Art and Science of Translating Trials Results Into Clinical Practice	23
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	23
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	23
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	23
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	23
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	22
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	22
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	22
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	22
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	22
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	22
Clinical Utility of Lipoprotein(a) for Screening Does Not Determine Clinical Utility of Lipoprotein(a) for the Patient	21
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	21
Blood Pressure Control After SPRINT—Back to Reality	21
Transient Monocular Blindness in a Man in His 30s	21
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	21
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	21
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	21
Authenticity—An Uphill Battle for a Black Woman in Cardiology	21
Error in Affiliations	21
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	21
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	21
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery	20
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	20
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	20
Women’s Representation in Interventional Cardiology	20
Genetic Testing in Early-Onset Atrial Fibrillation	20
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	20
Salt Substitution and Recurrent Stroke and Death—Reply	20
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	20
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	20
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	20
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	20
Hospitalization Rates Alone Do Not Define Health Systems—Reply	20
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events	19
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	19
Private Equity and Cardiovascular Health Care	19
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis	19
Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery	19
Error in Abstract and Methods	19
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction	19
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US	19
Long-term Survival After Out-of-Hospital Cardiac Arrest	18
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	18
Reducing the Risks of Nuclear War—The Role of Health Professionals	18
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	18
Omitted Affiliation	18
Error in the First Paragraph	18
Educational Attainment and Lifetime Risk of Cardiovascular Disease	18
Variants at the Interleukin 1 Gene Locus and Pericarditis	18
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	18
Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart	17
Can Noncalcified Plaques Contribute to Future Coronary Events?	17
Return to Play for Athletes After COVID-19 Infection	17
Error in Figure 1	17